MiR-92a Inhibits the Progress of Osteosarcoma Cells and Increases the Cisplatin Sensitivity by Targeting Notch1

Figure 6

MiR-92a inhibited osteosarcoma tumourigenesis and enhances cisplatin sensitivity in vivo. (a) Representative subcutaneous xenograft from the mice in different group. (b) The growth curve of subcutaneous xenografts of OG63 cells. Data represent mean ± SD. P < 0.05; P < 0.01.

(a)

(b)